Leadartis is part of the Genoma España´s Technology Portfolio

01-02-2008

In 2008 LeadArtis signed an agreement with Genoma España, and it has been incorporated to its Technology Portfolio (www.gen-es.com.es). The agreement supported the creation of the company and represented an infusion of resources to finance LeadArtis´start-up activities.

Latest News

Leadartis reaches a major milestone with the demonstration of absence of toxicity of its drug candidate in preclinical models
13-01-2021

Leadartis reaches a major milestone with the demonstration of...

Leadartis featured in EXPANSION as a ‘Start up’ that leads the fight against cancer
10-11-2020

...

Leadartis closes the investment round in 14 days with an overfunding of 25%
28-09-2020

We are pleased to inform you that the investment round has been successfully closed, raising a...